Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient

Infection. 2020 Oct;48(5):799-802. doi: 10.1007/s15010-020-01470-z. Epub 2020 Jun 26.

Abstract

In non-human immunodeficiency virus (HIV)-infected patients, tuberculosis (TB) immune reconstitution inflammatory syndrome (IRIS) is unusual. The management of corticosteroids-refractory IRIS is unclear. We report on infliximab efficacy for treatment of corticosteroid-resistant TB-IRIS occurring in an immunocompetent patient.

Keywords: Immune reconstitution inflammatory syndrome; Infliximab; Tuberculosis.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / pharmacology
  • Antitubercular Agents / therapeutic use*
  • Drug Resistance, Bacterial*
  • Female
  • France
  • Humans
  • Immune Reconstitution Inflammatory Syndrome / drug therapy*
  • Immunocompromised Host
  • Infliximab / therapeutic use*
  • Middle Aged
  • Tuberculosis / drug therapy*

Substances

  • Adrenal Cortex Hormones
  • Antitubercular Agents
  • Infliximab